Page last updated: 2024-08-23

substance p and fosaprepitant

substance p has been researched along with fosaprepitant in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Aapro, M; Carides, AD; Evans, JK; Hargreaves, R; Hesketh, PJ; Horgan, KJ; Naylor, RJ; Tattersall, FD; Van Belle, S	1
Abdel, MP; An, KN; Grill, DE; Kremers, HM; Lewallen, DG; Lewallen, EA; Morrey, ME; Reina, N; Salib, CG; Sanchez-Sotelo, J; Steinmann, SP; Trousdale, WH; van Wijnen, AJ; Yao, JJ	1
Barbariga, M; Bignami, F; Ferrari, G; Fonteyne, P; Lasagni Vitar, RM; Rama, P	1

Reviews

1 review(s) available for substance p and fosaprepitant

Article	Year
Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists. European journal of cancer (Oxford, England : 1990), 2003, Volume: 39, Issue:8 Topics: Antiemetics; Antineoplastic Agents; Aprepitant; Cisplatin; Clinical Trials, Phase II as Topic; Drug Therapy, Combination; Granisetron; Humans; Morpholines; Neoplasms; Neurokinin-1 Receptor Antagonists; Neurotransmitter Agents; Ondansetron; Prodrugs; Serotonin; Serotonin Antagonists; Substance P; Vomiting	2003

Article

Year

Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists.

European journal of cancer (Oxford, England : 1990), 2003, Volume: 39, Issue:8

Topics: Antiemetics; Antineoplastic Agents; Aprepitant; Cisplatin; Clinical Trials, Phase II as Topic; Drug Therapy, Combination; Granisetron; Humans; Morpholines; Neoplasms; Neurokinin-1 Receptor Antagonists; Neurotransmitter Agents; Ondansetron; Prodrugs; Serotonin; Serotonin Antagonists; Substance P; Vomiting

2003

Other Studies

2 other study(ies) available for substance p and fosaprepitant

Article	Year
Intra-articular injection of a substance P inhibitor affects gene expression in a joint contracture model. Journal of cellular biochemistry, 2018, Volume: 119, Issue:2 Topics: Animals; Biomechanical Phenomena; Contracture; Disease Models, Animal; Elbow Injuries; Elbow Joint; Gene Expression Profiling; Gene Expression Regulation; Gene Regulatory Networks; Humans; Injections; Morpholines; Oligonucleotide Array Sequence Analysis; Rabbits; Substance P	2018
Modulating Ocular Surface Pain Through Neurokinin-1 Receptor Blockade. Investigative ophthalmology & visual science, 2021, 03-01, Volume: 62, Issue:3 Topics: Administration, Ophthalmic; Animals; Cornea; Corneal Diseases; Disease Models, Animal; Eye Pain; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Neurokinin-1 Receptor Antagonists; Nociception; Ophthalmic Solutions; Substance P; Tears; Trigeminal Nerve	2021

Article

Year

Intra-articular injection of a substance P inhibitor affects gene expression in a joint contracture model.

Journal of cellular biochemistry, 2018, Volume: 119, Issue:2

Topics: Animals; Biomechanical Phenomena; Contracture; Disease Models, Animal; Elbow Injuries; Elbow Joint; Gene Expression Profiling; Gene Expression Regulation; Gene Regulatory Networks; Humans; Injections; Morpholines; Oligonucleotide Array Sequence Analysis; Rabbits; Substance P

2018

Modulating Ocular Surface Pain Through Neurokinin-1 Receptor Blockade.

Investigative ophthalmology & visual science, 2021, 03-01, Volume: 62, Issue:3

Topics: Administration, Ophthalmic; Animals; Cornea; Corneal Diseases; Disease Models, Animal; Eye Pain; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Neurokinin-1 Receptor Antagonists; Nociception; Ophthalmic Solutions; Substance P; Tears; Trigeminal Nerve

2021